Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Smith & Nephew plc (ADR) (SNN): Are Hedge Funds Right About This Stock?

Page 1 of 2

What’s a smart Smith & Nephew plc (ADR) (NYSE:SNN) investor to do?

To many of your peers, hedge funds are viewed as bloated, outdated investment vehicles of a period lost to current times. Although there are In excess of 8,000 hedge funds in operation currently, Insider Monkey aim at the crème de la crème of this club, around 525 funds. It is widely held that this group has its hands on the majority of all hedge funds’ total assets, and by monitoring their best picks, we’ve brought to light a few investment strategies that have historically outstripped Mr. Market. Our small-cap hedge fund strategy outperformed the S&P 500 index by 18 percentage points per year for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have topped the S&P 500 index by 33 percentage points in 11 months (find a sample of our picks).

Just as key, positive insider trading sentiment is another way to look at the financial markets. Obviously, there are a variety of stimuli for a bullish insider to downsize shares of his or her company, but just one, very simple reason why they would behave bullishly. Many academic studies have demonstrated the valuable potential of this method if you know what to do (learn more here).

Smith & Nephew plc (ADR) (NYSE:SNN)

Furthermore, let’s study the recent info for Smith & Nephew plc (ADR) (NYSE:SNN).

Hedge fund activity in Smith & Nephew plc (ADR) (NYSE:SNN)

At Q2’s end, a total of 7 of the hedge funds we track were long in this stock, a change of 17% from the first quarter. With the smart money’s sentiment swirling, there exists a few noteworthy hedge fund managers who were upping their holdings significantly.

Out of the hedge funds we follow, Ken Fisher’s Fisher Asset Management had the biggest position in Smith & Nephew plc (ADR) (NYSE:SNN), worth close to $58.9 million, comprising 0.2% of its total 13F portfolio. Coming in second is Peter Rathjens, Bruce Clarke and John Campbell of Arrowstreet Capital, with a $6.2 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Some other peers that hold long positions include David Dreman’s Dreman Value Management, Jim Simons’s Renaissance Technologies and D. E. Shaw’s D E Shaw.

Now, certain bigger names were leading the bulls’ herd. Fisher Asset Management, managed by Ken Fisher, initiated the biggest position in Smith & Nephew plc (ADR) (NYSE:SNN). Fisher Asset Management had 58.9 million invested in the company at the end of the quarter. Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital also made a $6.2 million investment in the stock during the quarter. The other funds with new positions in the stock are David Dreman’s Dreman Value Management, Jim Simons’s Renaissance Technologies, and D. E. Shaw’s D E Shaw.

How have insiders been trading Smith & Nephew plc (ADR) (NYSE:SNN)?

Bullish insider trading is at its handiest when the company in question has seen transactions within the past six months. Over the last 180-day time period, Smith & Nephew plc (ADR) (NYSE:SNN) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Smith & Nephew plc (ADR) (NYSE:SNN). These stocks are Varian Medical Systems, Inc. (NYSE:VAR), Zimmer Holdings, Inc. (NYSE:ZMH), Edwards Lifesciences Corp (NYSE:EW), St. Jude Medical, Inc. (NYSE:STJ), and Boston Scientific Corporation (NYSE:BSX). This group of stocks are in the medical appliances & equipment industry and their market caps are closest to SNN’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!